Company intelligence / Profile preview

Endolumik

Morgantown, West Virginia, United Statesendolumik.com ↗

Ownership: Private
Development stage: Commercial

Overview

Endolumik’s fluorescence-guided gastric calibration tube has received FDA clearance under the Safer Technologies Program. In a clinical trial involving 22 patients, there were no adverse results reported. The device is designed to improve visualization and accuracy during bariatric and gastric surgeries, aiming to reduce complications such as improper staple placement or accidental stapling of the calibration tube.

Therapeutic areas: Metabolic DisordersGastroenterology
Modalities: DeviceNon-pharmacological therapy (surgical tool)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Endolumik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endolumik.

Explore the full profile